| Identification | Back Directory | [Name]
N-[(2S)-2-(Glycoloylamino)-4-phenylbutanoyl]-L-leucyl-N-{(2S)-4-methyl-1-[(2R)-2-methyl-2-oxiranyl]-1-oxo-2-pentanyl}-L-phenylalaninamide | [CAS]
868540-02-7 | [Synonyms]
Enzyme-IN-1
N-[(2S)-2-(Glycoloylamino)-4-phenylbutanoyl]-L-leucyl-N-{(2S)-4-methyl-1-[(2R)-2-methyl-2-oxiranyl]-1-oxo-2-pentanyl}-L-phenylalaninamide
L-Phenylalaninamide, (αS)-α-[(hydroxyacetyl)amino]benzenebutanoyl-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyloxiranyl]carbonyl]butyl]- (9CI) | [Molecular Formula]
C36H50N4O7 | [MOL File]
868540-02-7.mol | [Molecular Weight]
650.82 |
| Chemical Properties | Back Directory | [Boiling point ]
953.7±65.0 °C(Predicted) | [density ]
1.177±0.06 g/cm3(Predicted) | [form ]
Solid | [pka]
13.17±0.46(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
Enzyme-IN-1 (compound 1) is a peptide-based inhibitor of N-terminal nucleophile (Ntn) hydrolases. Specifically, Enzyme-IN-1 inhibits the chymotrypsin-like activity (CT-L) of the 20S proteasome. Enzyme-IN-1 may has potential antiinflammatory properties[1]. | [References]
[1] Smyth Mark, et al. Preparation of peptides for the inhibition of enzymes. United States, US20050245435 A1. 2005-11-03. |
|
|